Judy Alberto, MHA, RPh, BCOP, director of clinical initiatives at the Community Oncology Alliance (COA), addresses the challenges pharmacies face in managing formularies to provide optimal patient care.
Judy Alberto, MHA, RPh, BCOP, director of clinical initiatives at the Community Oncology Alliance (COA), is 1 of 5 panelists for today's discussion, "Managing Formularies: Successfully Navigating Multiple Formularies to Balance Clinical & Financial Outcomes,” taking place during the 2024 Community Oncology Conference.
Here, she addresses the challenges pharmacies face in managing formularies to provide optimal patient care and addresses CMS’ controversial Stark Law interpretation. Patients are suffering, Alberto emphasizes when discussing this provision, as they struggle to access necessary medications and their health care providers face dilemmas regarding compliance with this interpretation.
Transcript
Can you outline the focus of your presentation, and the significance of managing formularies for optimal clinical and financial outcomes?
Our panel on managing formulary outcomes is going to focus on the landscape of pharmacy: what the challenges are facing pharmacists who have to manage the formulary and then how they overcome those challenges and what they implement to successfully be able to treat patients and keep the lights on at their institution.
Why is it important to approach formulary management with clinical and financial outcomes in mind?
If you look at something like the IHI [Institute for Healthcare Improvement], the Triple Aim is keeping patients’ satisfaction high, which includes a good quality; lowering cost of care; and also increasing clinical outcomes. This all comes into play when you're managing a formulary, and again, keeping those lights on so you can treat not only current patients, but future patients. We have a responsibility to make sure that we're always doing the right thing for the patients that are waiting to be treated, as well as the patients we are currently treating.
How is CMS’ Stark Law interpretation of mailing/couriering oral cancer drugs negatively affecting patients and health care providers?
It's a real struggle, as you can imagine, that cancer patients sometimes cannot leave their home to go pick up their oral anticancer medication. We're really seeing that this is impacting those patients. We've had examples of patients whose family members have passed away and they were still forced to go into the office to pick up their medication because it can't be mailed to them. It affects the providers because now they have to decide, do they ignore this interpretation and risk fines and penalties for mailing medications or do they adhere to what this interpretation is and force patients to come in? This excludes even family members being allowed to pick up medications for their loved ones. And so it has a significant impact on both the providers and the patients alike.
What are the long-term ramifications if this provision is not overturned?
The long-term ramifications are patients are suffering, it could delay their care, it could impact their clinical outcomes, and they may choose to go to another pharmacy that's not as convenient for them. We know that when PBMs [pharmacy benefit managers] are involved in mail order, the entire landscape for patients changes. Those PBMs don't have access to the records, sometimes it can take weeks for them to get the medication, so we really want to keep it in the hands of their independent community oncology practices.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Health Equity and Access Weekly Roundup: April 27, 2024
April 27th 2024Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Health Equity and Access Weekly Roundup: April 27, 2024
April 27th 2024Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
2 Commerce Drive
Cranbury, NJ 08512